Quest Partners LLC Dyne Therapeutics, Inc. Transaction History
Quest Partners LLC
- $737 Billion
- Q2 2024
A detailed history of Quest Partners LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 344 shares of DYN stock, worth $11,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
344
Previous 165
108.48%
Holding current value
$11,575
Previous $4.68 Million
159.18%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
201Shares Held
106MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$270 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$264 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$249 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$215 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$204 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.74B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...